SULFINPYRAZONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sulfinpyrazone, and when can generic versions of Sulfinpyrazone launch?
Sulfinpyrazone is a drug marketed by Barr, Ivax Pharms, Par Pharm, Vangard, and Watson Labs. and is included in eight NDAs.
The generic ingredient in SULFINPYRAZONE is sulfinpyrazone. There are four drug master file entries for this compound. Additional details are available on the sulfinpyrazone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SULFINPYRAZONE?
- What are the global sales for SULFINPYRAZONE?
- What is Average Wholesale Price for SULFINPYRAZONE?
Summary for SULFINPYRAZONE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 99 |
| Clinical Trials: | 3 |
| Patent Applications: | 3,940 |
| DailyMed Link: | SULFINPYRAZONE at DailyMed |
Recent Clinical Trials for SULFINPYRAZONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
| Federal University of São Paulo | Phase 4 |
| China Medical University Hospital | Phase 2 |
Medical Subject Heading (MeSH) Categories for SULFINPYRAZONE
Anatomical Therapeutic Chemical (ATC) Classes for SULFINPYRAZONE
US Patents and Regulatory Information for SULFINPYRAZONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr | SULFINPYRAZONE | sulfinpyrazone | CAPSULE;ORAL | 087666-001 | Sep 17, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Par Pharm | SULFINPYRAZONE | sulfinpyrazone | TABLET;ORAL | 088933-001 | Sep 6, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Vangard | SULFINPYRAZONE | sulfinpyrazone | CAPSULE;ORAL | 088666-001 | Feb 17, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | SULFINPYRAZONE | sulfinpyrazone | TABLET;ORAL | 087667-001 | May 26, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ivax Pharms | SULFINPYRAZONE | sulfinpyrazone | CAPSULE;ORAL | 087770-001 | Nov 19, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Par Pharm | SULFINPYRAZONE | sulfinpyrazone | CAPSULE;ORAL | 088934-001 | Sep 6, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ivax Pharms | SULFINPYRAZONE | sulfinpyrazone | TABLET;ORAL | 087769-001 | Jun 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
